Article info
PDFUterine Cancer
Evaluation of TOP2A as a Predictive Marker for Endometrial Cancer With Taxane-Containing Adjuvant Chemotherapy
- Address correspondence and reprint requests to Naoto Furukawa, MD, Department of Obstetrics and Gynecology, Nara Prefecture Western Medical Center, 1-14-16 Mimuro, Sango-cho, Ikoma-gun, Nara 636-0802, Japan. E-mail: furunao0813@gmail.com.
Citation
Evaluation of TOP2A as a Predictive Marker for Endometrial Cancer With Taxane-Containing Adjuvant Chemotherapy
Publication history
- Received August 12, 2015
- First published February 1, 2016.
Online issue publication
February 26, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright © 2016 by IGCS and ESGO